A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling.

USA115^th CongressS-3519| Senate

| Updated: 9/27/2018

Making Objective Drug Evidence Revisions for New Labeling Act or the MODERN Labeling Act This bill amends the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with authority to require updates to drug labeling to reflect new information relevant to the drug and its use.

View Full Text

Health

A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling.

USA115^th CongressS-3519| Senate

| Updated: 9/27/2018

View Full Text

Orrin G. Hatch

Republican Senator

Utah

Cosponsors (1)

Michael F. Bennet (Democratic)

Health, Education, Labor, and Pensions Committee

Health

Introduced
In Committee
On Floor
Passed Chamber
Enacted

A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling.

Suggested Questions

Health

A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling.

Suggested Questions

Orrin G. Hatch

Health, Education, Labor, and Pensions Committee

Health

A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling.

Suggested Questions

Health

A bill to establish a process for the Food and Drug Administration to determine whether to modify the labeling of drugs whose labeling may be outdated, including drugs with accepted uses that are not reflected in the approved labeling.

Suggested Questions

Orrin G. Hatch

Health, Education, Labor, and Pensions Committee

Health